Sponsor:
Supernus Pharmaceuticals, Inc.
Code:
NCT04781140
Conditions
Attention-Deficit/Hyperactivity Disorder
Eligibility Criteria
Sex: All
Age: 48 - 69
Healthy Volunteers: Not accepted
Interventions
100mg SPN-812
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations